BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 10699107)

  • 61. Prevention of chronic lung disease in preterm infants by early postnatal dexamethasone therapy.
    Lin YJ; Yeh TF; Hsieh WS; Chi YC; Lin HC; Lin CH
    Pediatr Pulmonol; 1999 Jan; 27(1):21-6. PubMed ID: 10023787
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Hydrocortisone to Improve Survival without Bronchopulmonary Dysplasia.
    Watterberg KL; Walsh MC; Li L; Chawla S; D'Angio CT; Goldberg RN; Hintz SR; Laughon MM; Yoder BA; Kennedy KA; McDavid GE; Backstrom-Lacy C; Das A; Crawford MM; Keszler M; Sokol GM; Poindexter BB; Ambalavanan N; Hibbs AM; Truog WE; Schmidt B; Wyckoff MH; Khan AM; Garg M; Chess PR; Reynolds AM; Moallem M; Bell EF; Meyer LR; Patel RM; Van Meurs KP; Cotten CM; McGowan EC; Hines AC; Merhar S; Peralta-Carcelen M; Wilson-Costello DE; Kilbride HW; DeMauro SB; Heyne RJ; Mosquera RA; Natarajan G; Purdy IB; Lowe JR; Maitre NL; Harmon HM; Hogden LA; Adams-Chapman I; Winter S; Malcolm WF; Higgins RD;
    N Engl J Med; 2022 Mar; 386(12):1121-1131. PubMed ID: 35320643
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The interval between a single course of antenatal steroids and delivery and its association with neonatal outcomes.
    Peaceman AM; Bajaj K; Kumar P; Grobman WA
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1165-9. PubMed ID: 16157131
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of pulse dexamethasone therapy on the incidence and severity of chronic lung disease in the very low birth weight infant.
    Brozanski BS; Jones JG; Gilmour CH; Balsan MJ; Vazquez RL; Israel BA; Newman B; Mimouni FB; Guthrie RD
    J Pediatr; 1995 May; 126(5 Pt 1):769-76. PubMed ID: 7752005
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Clinical characteristics and risk factors of very low birth weight and extremely low birth weight infants with bronchopulmonary dysplasia: multicenter retrospective analysis].
    Jiangsu Multicenter Study Collaborative Group for Breastmilk Feeding in Neonatal Intensive Care Units
    Zhonghua Er Ke Za Zhi; 2019 Jan; 57(1):33-39. PubMed ID: 30630229
    [No Abstract]   [Full Text] [Related]  

  • 66. The Randomized, Controlled Trial of Late Surfactant: Effects on Respiratory Outcomes at 1-Year Corrected Age.
    Keller RL; Eichenwald EC; Hibbs AM; Rogers EE; Wai KC; Black DM; Ballard PL; Asselin JM; Truog WE; Merrill JD; Mammel MC; Steinhorn RH; Ryan RM; Durand DJ; Bendel CM; Bendel-Stenzel EM; Courtney SE; Dhanireddy R; Hudak ML; Koch FR; Mayock DE; McKay VJ; Helderman J; Porta NF; Wadhawan R; Palermo L; Ballard RA;
    J Pediatr; 2017 Apr; 183():19-25.e2. PubMed ID: 28100402
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Dexamethasone therapy for chronic lung disease in ventilator- and oxygen-dependent infants: a controlled trial.
    Harkavy KL; Scanlon JW; Chowdhry PK; Grylack LJ
    J Pediatr; 1989 Dec; 115(6):979-83. PubMed ID: 2685220
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A comparison of 7-day versus 10-day course of low-dose dexamethasone for chronically ventilated preterm infants.
    Cuna A; Govindarajan S; Oschman A; Dai H; Brophy K; Norberg M; Truog W
    J Perinatol; 2017 Mar; 37(3):301-305. PubMed ID: 27906194
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Bronchopulmonary dysplasia. Retrospective analysis of various forms of treatment and development of a staged therapeutic plan].
    Bauer J; Beedgen B; Böhler T; Sontheimer D; Zilow EP; Linderkamp O
    Klin Padiatr; 1996; 208(2):56-60. PubMed ID: 8901183
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: a double-blind, controlled study.
    Yeh TF; Torre JA; Rastogi A; Anyebuno MA; Pildes RS
    J Pediatr; 1990 Aug; 117(2 Pt 1):273-82. PubMed ID: 2199642
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Adverse effects of early dexamethasone treatment in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network.
    Stark AR; Carlo WA; Tyson JE; Papile LA; Wright LL; Shankaran S; Donovan EF; Oh W; Bauer CR; Saha S; Poole WK; Stoll BJ;
    N Engl J Med; 2001 Jan; 344(2):95-101. PubMed ID: 11150359
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Early dexamethasone therapy in preterm infants: a follow-up study.
    Yeh TF; Lin YJ; Huang CC; Chen YJ; Lin CH; Lin HC; Hsieh WS; Lien YJ
    Pediatrics; 1998 May; 101(5):E7. PubMed ID: 9565440
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Early inhaled nitric oxide therapy in premature newborns with respiratory failure.
    Kinsella JP; Cutter GR; Walsh WF; Gerstmann DR; Bose CL; Hart C; Sekar KC; Auten RL; Bhutani VK; Gerdes JS; George TN; Southgate WM; Carriedo H; Couser RJ; Mammel MC; Hall DC; Pappagallo M; Sardesai S; Strain JD; Baier M; Abman SH
    N Engl J Med; 2006 Jul; 355(4):354-64. PubMed ID: 16870914
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Late (> 7 days) postnatal corticosteroids for chronic lung disease in preterm infants.
    Doyle LW; Ehrenkranz RA; Halliday HL
    Cochrane Database Syst Rev; 2014 May; (5):CD001145. PubMed ID: 24825542
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: outcome of study participants at 1-year adjusted age.
    O'Shea TM; Kothadia JM; Klinepeter KL; Goldstein DJ; Jackson BG; Weaver RG; Dillard RG
    Pediatrics; 1999 Jul; 104(1 Pt 1):15-21. PubMed ID: 10390254
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Methylprednisolone, an alternative to dexamethasone in very premature infants at risk of chronic lung disease.
    André P; Thébaud B; Odièvre MH; Razafimahefa H; Zupan V; Dehan M; Lacaze-Masmonteil T
    Intensive Care Med; 2000 Oct; 26(10):1496-500. PubMed ID: 11126262
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Timing of postnatal corticosteroid treatment for bronchopulmonary dysplasia and its effect on outcomes.
    Cuna A; Lewis T; Dai H; Nyp M; Truog WE
    Pediatr Pulmonol; 2019 Feb; 54(2):165-170. PubMed ID: 30537393
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia.
    Mammel MC; Green TP; Johnson DE; Thompson TR
    Lancet; 1983 Jun; 1(8338):1356-8. PubMed ID: 6134136
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Early dexamethasone therapy and blood cell count in preterm infants.
    Peng CT; Lin HC; Lin YJ; Tsai CH; Yeh TF
    Pediatrics; 1999 Sep; 104(3 Pt 1):476-81. PubMed ID: 10469772
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pulse dexamethasone does not impair growth and body composition of very low birth weight infants.
    Gilmour CH; Sentipal-Walerius JM; Jones JG; Doyle JM; Brozanski BS; Balsan MJ; Mimouni FB
    J Am Coll Nutr; 1995 Oct; 14(5):455-62. PubMed ID: 8522724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.